Silo Pharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Sarasota, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Silo Pharma, Inc. has filed 376 SEC EDGAR filings since 30 Mar 2011

SEC filing history

Showing 176-200 of 376 matching filings.

Per page
25
Current page
8
8-A12B File 001-41512

FOR REGISTRATION OF CERTAIN CLASSES

Filing date
26 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-261532

AMENDMENT NO. 4 TO FORM S-1

Filing date
20 Sep 2022
Reporting date
Not listed
Next action
Verify source filing
8-K File 000-54872

CURRENT REPORT

Filing date
15 Sep 2022
Reporting date
14 Sep 2022
Next action
Verify source filing
S-1/A File 333-261532

AMENDMENT NO. 3 TO FORM S-1

Filing date
09 Sep 2022
Reporting date
Not listed
Next action
Verify source filing
S-1/A File 333-261532

AMENDMENT NO. 2 TO FORM S-1

Filing date
29 Aug 2022
Reporting date
Not listed
Next action
Verify source filing
10-Q File 000-54872

QUARTERLY REPORT

Filing date
01 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
S-1/A File 333-261532

AMENDMENT NO. 1 TO FORM S-1

Filing date
25 Jul 2022
Reporting date
Not listed
Next action
Verify source filing
4

4 filing

Filing date
21 Jun 2022
Reporting date
17 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54872

QUARTERLY REPORT

Filing date
13 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
10-K File 000-54872

ANNUAL REPORT

Filing date
28 Mar 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
DEFA14A File 000-54872

DEFINITIVE ADDITIONAL MATERIALS

Filing date
07 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54872

CURRENT REPORT

Filing date
07 Mar 2022
Reporting date
07 Mar 2022
Next action
Verify source filing
DEF 14A File 000-54872

DEFINITIVE PROXY STATEMENT

Filing date
14 Feb 2022
Reporting date
11 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-54872

PRELIMINARY PROXY STATEMENT

Filing date
02 Feb 2022
Reporting date
02 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

OWNERSHIP DOCUMENT

Filing date
05 Jan 2022
Reporting date
29 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54872

CURRENT REPORT

Filing date
04 Jan 2022
Reporting date
29 Dec 2021
Next action
Verify source filing
4

4 filing

Filing date
03 Jan 2022
Reporting date
29 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jan 2022
Reporting date
29 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
15 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Dec 2021
Reporting date
10 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-261532

REGISTRATION STATEMENT

Filing date
07 Dec 2021
Reporting date
Not listed
Next action
Verify source filing
10-Q File 000-54872

QUARTERLY REPORT

Filing date
10 Nov 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .